Treace Medical Concepts, Inc. (TMCI) Gross margin 2019–2025
Treace Medical Concepts, Inc. (TMCI) gross margin by fiscal year — reported gross profit divided by reported revenue.
79.8%FY2025 · since FY2019: 80.6% → 79.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 79.8% | -0.6 pp |
| FY2024 | 80.4% | -0.8 pp |
| FY2023 | 81.2% | -0.8 pp |
| FY2022 | 82.0% | -0.1 pp |
| FY2021 | 82.1% | +3.9 pp |
| FY2020 | 78.3% | -2.4 pp |
| FY2019 | 80.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Net marginTMCI Gross profitTMCI Operating incomeTMCI Operating marginTMCI Operating cash flowTMCI Free cash flowTMCI Capital expendituresTMCI Return on equityTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →